-
1.
公开(公告)号:WO2021162665A1
公开(公告)日:2021-08-19
申请号:PCT/TR2021/050119
申请日:2021-02-10
发明人: DOĞAN, Berna , DURDAĞI, Serdar , ÇAÇAN, Gurbet , ÇALIŞ, Şeyma , AVŞAR, Timuçin , ORHAN, Müge Didem
IPC分类号: C07D277/02 , A61K31/426 , A61P35/00
摘要: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
-
2.
公开(公告)号:WO2021162667A1
公开(公告)日:2021-08-19
申请号:PCT/TR2021/050121
申请日:2021-02-10
发明人: ORHAN, Müge Didem , DOĞAN, Berna , ÇALIŞ, Şeyma , ÇAÇAN, Gurbet , AVŞAR, Timuçin , DURDAĞI, Serdar
IPC分类号: A61P35/00 , C07D213/00 , C07D213/04
摘要: The invention relates to compound shown with formula (I) for a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
-
3.
公开(公告)号:WO2021162666A1
公开(公告)日:2021-08-19
申请号:PCT/TR2021/050120
申请日:2021-02-10
发明人: DURDAĞI, Serdar , AVŞAR, Timuçin , ORHAN, Müge Didem , ÇAÇAN, Gurbet , DOĞAN, Berna , ÇALIŞ, Şeyma
IPC分类号: A61P35/00 , A61K31/12 , A61K31/4035 , A61K31/428 , C07D417/12 , C07D277/62
摘要: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of BCL-2.
-
公开(公告)号:WO2021167571A1
公开(公告)日:2021-08-26
申请号:PCT/TR2021/050144
申请日:2021-02-17
发明人: DURDAĞI, Serdar , ORHAN, Müge Didem , AVŞAR, Timuçin , YURTSEVER, Mine , PAKSOY, Maide Nur , AYDIN, Gülşah
IPC分类号: A61K31/405 , A61P35/00 , C07D413/00
摘要: The invention relates to compound shown with formula I or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
-
公开(公告)号:WO2021167570A1
公开(公告)日:2021-08-26
申请号:PCT/TR2021/050143
申请日:2021-02-16
发明人: AVŞAR, Timuçin , DURDAĞI, Serdar , ORHAN, Müge Didem , PAKSOY, Maide Nur , AYDIN, Gülşah , YURTSEVER, Mine
IPC分类号: C07D209/08 , A61P35/02 , A61K31/404
摘要: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
-
公开(公告)号:WO2021173102A1
公开(公告)日:2021-09-02
申请号:PCT/TR2021/050170
申请日:2021-02-25
摘要: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MAO-B.
-
公开(公告)号:WO2021167572A1
公开(公告)日:2021-08-26
申请号:PCT/TR2021/050145
申请日:2021-02-17
发明人: DURDAĞI, Serdar , ORHAN, Müge Didem , AVŞAR, Timuçin , PAKSOY, Maide Nur , AYDIN, Gülşah , YURTSEVER, Mine
IPC分类号: A61P35/00 , C07D209/08 , A61K31/404
摘要: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
-
8.
公开(公告)号:WO2021173103A1
公开(公告)日:2021-09-02
申请号:PCT/TR2021/050171
申请日:2021-02-25
IPC分类号: A61K31/16 , C07D235/04 , C07D231/02 , A61P25/28
摘要: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MAO-B.
-
公开(公告)号:WO2021167575A1
公开(公告)日:2021-08-26
申请号:PCT/TR2021/050148
申请日:2021-02-17
发明人: YURTSEVER, Mine , ORHAN, Müge Didem , PAKSOY, Maide Nur , AYDIN, Gülşah , AVŞAR, Timuçin , DURDAĞI, Serdar
IPC分类号: A61P35/02 , A61K31/404 , C07D209/08
摘要: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
-
公开(公告)号:WO2021167574A1
公开(公告)日:2021-08-26
申请号:PCT/TR2021/050147
申请日:2021-02-17
发明人: DURDAĞI, Serdar , AVŞAR, Timuçin , YURTSEVER, Mine , AYDIN, Gülşah , PAKSOY, Maide Nur , ORHAN, Müge Didem
IPC分类号: A61K31/407 , A61K31/4439 , A61P35/00 , C07D209/00
摘要: The invention relates to compound shown with formula (I) or a pharmaceutically acceptable derivative thereof for use as a novel inhibitor of MDM2 activity.
-
-
-
-
-
-
-
-
-